NCT00286793 2011-06-29
Safety and Efficacy Study of AT-101 in Combination With Docetaxel and Prednisone in Men With HRPC
Ascenta Therapeutics
Phase 1/2 Completed
Ascenta Therapeutics
Ascenta Therapeutics
Ascenta Therapeutics
Ascenta Therapeutics
Ascenta Therapeutics